AstraZeneca chops 210 workers, closes sites as it looks to concentrate biologics manufacturing in one place

AstraZeneca is closing down two manufacturing sites in Colorado that collectively employed 210 workers, in an apparent effort to consolidate its biologics supply chain.

First reported in a WARN notice on Tuesday, the layoffs are “unrelated” to the organizational changes announced a day prior, spokesperson Michele Meixell told me in an email.